Gossamer Bio: Vanguard Reports 0 Shares Beneficially Owned
Gossamer Bio Inc Schedule 13G/A (Amendment No. 6) reports that The Vanguard Group holds 0 shares of Common Stock and beneficial ownership of 0% of the class as disclosed.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Gossamer Bio Inc Schedule 13G/A (Amendment No. 6) reports that The Vanguard Group holds 0 shares of Common Stock and beneficial ownership of 0% of the class as disclosed. The filing explains an internal realignment effective January 12, 2026 that caused certain Vanguard subsidiaries or divisions to report holdings separately.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Amendment No. 6 to the Schedule 13G/A for GOSS indicate?
Who signed the Schedule 13G/A amendment for Gossamer Bio (GOSS)?
AI-generated analysis. How Rhea-AI works. Not financial advice.